Summary
Pfizer Inc. (PFE) filed an 8-K on July 20, 2005, to report its financial results for the second quarter of 2005. The core of this filing is a press release, attached as Exhibit 99.1, which provides the company's performance data for the period ended July 19, 2005. Investors should note that this 8-K is primarily an announcement mechanism for the quarterly earnings. The actual detailed financial figures and management's commentary on the results are contained within the referenced press release. Therefore, a thorough review of Exhibit 99.1 is necessary for a complete understanding of Pfizer's second-quarter performance, including revenue, earnings, and any forward-looking statements or strategic updates provided by the company.
Key Highlights
- 1Pfizer Inc. (PFE) reported its second-quarter 2005 financial results on July 20, 2005.
- 2The official announcement of these results was made via a press release.
- 3The press release, dated July 20, 2005, is included as Exhibit 99.1 to this 8-K filing.
- 4This filing serves as the official notification to the SEC regarding Pfizer's quarterly performance.
- 5Investors seeking details on the second-quarter financial condition and results of operations should refer to Exhibit 99.1.